Recent

% | $
Quotes you view appear here for quick access.

Spherix Incorporated Message Board

  • investora2z investora2z Nov 3, 2013 9:57 AM Flag

    SA article

    Alexander Poltorak, who has extensive experience in the IP monetization industry, was recently appointed as a director in the company. Poltorak was the Chairman and CEO of General Patent, an intellectual property management firm focusing on IP strategy and valuation, patent licensing, enforcement and brokerage. On his appointment, Hayes stated that Poltorak's extensive experience in the patent monetization industry will provide valuable governance leadership to Spherix. This has also been mentioned in an article on seekingalpha. The author stated that Poltorak is a pioneer in this industry and has looked at more patents than almost anyone over the past couple of decades. He has spent his working life focused squarely on the intellectual property business, and his decision to join Spherix is another strong indication of the quality of the company's portfolio. In addition, the deal with Rockstar and the fact that Hayes is at the helm makes a case for investment in the stock. However, the author also mentions that it is difficult to value the patents owned by Spherix, and the stock is extremely volatile due to the low float. The transaction with Rockstar involved acceptance of shares of Spherix as consideration and also a share in future profits from the patents granted to Spherix. So Rockstar is turning the patents over to Spherix which is highly motivated to extract value from them. The track record of Hayes is well known, and the fact that Hayes has joined Spherix is an indication of the value that he sees in these patents. Amongst the risk factors, the author mentions that Spherix is just beginning to explore ways to extract value from the patents, and there is no significant current cash flow from these patents. It is also difficult to predict the future cash flows these patents may generate.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SPEX
0.2397+0.0100(+4.35%)Jul 30 3:59 PMEDT